|
Oncogenes and Tumor Suppressors
Citations 361-370 of 795 total displayed.
|
Past content
(since May 2000):
|
Immunohistochemistry accurately predicts FGFR3 aberrant expression and t(4;14) in multiple myeloma
- Hong Chang, A. Keith Stewart, Xiao Ying Qi, Zhi Hua Li, Qi Long Yi, and Suzanne Trudel
Blood 2005; 106: 353-355.
[Abstract]
[Full text]
[PDF]
Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation
- Paula G. Heller, Ana C. Glembotsky, Manish J. Gandhi, Carrie L. Cummings, Carlos J. Pirola, Rosana F. Marta, Laura I. Kornblihtt, Jonathan G. Drachman, and Felisa C. Molinas
Blood 2005; 105: 4664-4670.
[Abstract]
[Full text]
[PDF]
Stress-induced activation of the p53 tumor suppressor in leukemia cells and normal lymphocytes requires mitochondrial activity and reactive oxygen species
- Leonid Karawajew, Peter Rhein, Grit Czerwony, and Wolf-Dieter Ludwig
Blood 2005; 105: 4767-4775.
[Abstract]
[Full text]
[PDF]
FLT3-ITD and tyrosine kinase domain mutants induce 2 distinct phenotypes in a murine bone marrow transplantation model
- Rebekka Grundler, Cornelius Miething, Christian Thiede, Christian Peschel, and Justus Duyster
Blood 2005; 105: 4792-4799.
[Abstract]
[Full text]
[PDF]
Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32)
- Kim De Keersmaecker, Carlos Graux, Maria D. Odero, Nicole Mentens, Riet Somers, Johan Maertens, Iwona Wlodarska, Peter Vandenberghe, Anne Hagemeijer, Peter Marynen, and Jan Cools
Blood 2005; 105: 4849-4852.
[Abstract]
[Full text]
[PDF]
On the molecular origins of the chronic myeloproliferative disorders: it all makes sense
- Kenneth Kaushansky
Blood 2005; 105: 4187-4190.
[Full text]
[PDF]
Asparagine synthetase expression is linked with L-asparaginase resistance in TEL-AML1–negative but not TEL-AML1–positive pediatric acute lymphoblastic leukemia
- Wendy A. G. Stams, Monique L. den Boer, Amy Holleman, Inge M. Appel, H. Berna Beverloo, Elisabeth R. van Wering, Gritta E. Janka-Schaub, William E. Evans, and Rob Pieters
Blood 2005; 105: 4223-4225.
[Abstract]
[Full text]
[PDF]
Shared and distinct roles mediated through C-terminal subdomains of acute myeloid leukemia/Runt-related transcription factor molecules in murine development
- Yoko Fukushima-Nakase, Yoshinori Naoe, Ichiro Taniuchi, Hajime Hosoi, Tohru Sugimoto, and Tsukasa Okuda
Blood 2005; 105: 4298-4307.
[Abstract]
[Full text]
[PDF]
TEF, an antiapoptotic bZIP transcription factor related to the oncogenic E2A-HLF chimera, inhibits cell growth by down-regulating expression of the common  chain of cytokine receptors
- Takeshi Inukai, Toshiya Inaba, Jinjun Dang, Ryoko Kuribara, Keiya Ozawa, Atsushi Miyajima, Wenshu Wu, A. Thomas Look, Yojiro Arinobu, Hiromi Iwasaki, Koichi Akashi, Keiko Kagami, Kumiko Goi, Kanji Sugita, and Shinpei Nakazawa
Blood 2005; 105: 4437-4444.
[Abstract]
[Full text]
[PDF]
Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome
- Fanny Rubio-Moscardo, Joan Climent, Reiner Siebert, Miguel A. Piris, Jose I. Martín-Subero, Inga Nieländer, Javier Garcia-Conde, Martin J. S. Dyer, Maria Jose Terol, Daniel Pinkel, and Jose A. Martinez-Climent
Blood 2005; 105: 4445-4454.
[Abstract]
[Full text]
[PDF]
|
|
